The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...

The agency told vaccine makers that COVID-19 vaccines used in the United States starting in fall 2025 should be based on JN.1 ...

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

We want to know more about what these products are doing,” said Dr. Vinay Prasad during a recent FDA livestreamed ...

Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...

This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing ...

The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

The Food and Drug Administration (FDA) announced plans to significantly curtail people’s access to Covid-19 vaccines.

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

The U.S. Food and Drug Administration’s decision to limit COVID vaccines to people 65 and older and others with underlying ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...